Blood Group Typing Market Forecasts to 2028 – Global Analysis By Product (Consumables, Instruments and Other Products), Techniques (Assay-Based Techniques, Massively Parallel Sequencing Techniques, PCR-Based & Microarray Techniques and Other Techniques), Test Type (Antibody Screening & Identification, Antigen Typing and Other Test Types), End User and By Geography
According to Stratistics MRC, the Global Blood Group Typing Market is accounted for $1.80 billion in 2022 and is expected to reach $3.47 billion by 2028 growing at a CAGR of 11.5% during the forecast period. Blood typing is a method of telling what type of blood a person has. Blood typing is done so one can safely donate their blood or receive a blood transfusion. It is also done to see if one has substance called Rh factor on the surface of red blood cells. Blood typing plays a crucial role in blood transfusion and donations. It is a fast and easy method used to make sure that the donor and recipient are compatible to avoid any complications. It is very critical in pregnant women as mismatched blood transfusion can result in agglutination or blood clumping, which is essentially fatal.
According to the article published by Sarah Megginson, 89% of Australian adults participate in sports every year, with 62% participating at least three times a week. Hence, these cases of accidents will contribute to the increasing demand for the blood banks segment. In addition, in the past few years, the burden of blood-borne diseases has also increased, coupled with the increasing prevalence of transfusion transmissible infection and surgeries, growing awareness about blood donation, and several government initiatives associated with blood donation.
Market Dynamics:
Driver:
Increasing in the number of emergencies, road accidents and trauma cases
An increasing number of road accidents, emergencies, and trauma cases requiring blood transfusions, and the need for grouping of the blood in pregnancy are driving the growth of the market. Growing demand for blood group typing in prenatal testing, rising usage of blood group typing in forensic sciences and strict governing standards for blood transfusion is also boosting the global blood group typing market growth.
Restraint:
Lack of infrastructure and trained personnel
Due to Lack of infrastructure and trained personnel there might be clerical errors or technical problems with a sample or during testing. Intrinsic problems within red cells or plasma may also lead to ABO discrepancies. The test cannot be conducted for weakly or rarely reactive antigens from which the results are difficult to interpret, and additionally, a low titer of anti-A or anti-B could lead to false positive or false negative results hampering the market.
Opportunity:
Safe donation
Blood group typing helps us in identifying the blood group and helps to know the compatibility of the blood when transfused to another person, if not there are chances of getting infected with diseases or the condition that the donor has, some of the blood transfused diseases are HIV, AIDS etc. which are life threatening. Hence as this blood group typing is a necessary element in blood transfusion there are greater opportunities of driving the market.
Threat:
Transmission of infectious disease due to lack of hygiene
The blood group typing is done not only to detect or identify the blood group but also to detect infections, diagnose autoimmune disorders, as well as to diagnose certain diseased conditions the rapid antigen test is suitable for diagnosing infections in care settings, like GP surgeries and out-of-hours services. It directly detects the presence or absence of an antigen. HIV antigen is useful because the p24 antigen rises soon after infection and sooner than antibodies thus this can also lead to transfusion of infection due to lack of hygiene at the premises of blood group typing and thus hinders the market growth.
Covid-19 Impact
The COVID 19 pandemic has resulted in a decline in the number of the blood transfusions and donations, manufacturing and supply chain issues, and a decrease in the number of the visits to healthcare facilities leading to reduced usage of these diagnostic products. On the other hand the demand for blood group typing has increased subsequently. Many individuals with weak immune systems have been infected by COVID-19 and hospitalized and may require a blood transfusion due to COVID-19. As a result, the demand for blood group typing has risen during COVID-19, following the pandemic..
The pcr-based & microarray techniques segment is expected to be the largest during the forecast period
The pcr-based & microarray techniques segment is estimated to have a lucrative growth, due to its idea property to screen a lot of genes in one step and is very sensitive, highly quantitative and requires up to 1000-fold less RNA. Both allow a relative and accurate quantification of mRNA molecules with a sufficiently high repeatability and low variability. This technique makes it possible to examine the expression of thousands of genes simultaneously.
The antigen typing segment is expected to have the highest CAGR during the forecast period
The antigen typing segment is anticipated to witness the fastest CAGR growth during the forecast period, due to its use in identifying specific antigens on the red cell. Identification of specific red cell antigens of the father may be useful in assessing the risk of haemolytic disease of the newborn, which helps in obtaining phenotypically compatible units to search for rare blood types and to increase the reliability of repositories of antigen which in turn helps in booting the growth of the blood group typing market.
Region with highest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to the availability of favourable compensation policies and increasing occurrence of chronic disorders in this region and escalating incidence of chronic diseases, many of which require blood type determination for effective treatment and surging number of trauma and accident victims, who require instant blood transfusion are driving the market growth in this region.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period, owing to increase in the number of road accidents and the rising prevalence of chronic diseases are the major factors driving the growth of the market the increasing road fatalities and crashes are increasing the demand for blood group typing. This is expected to augment the demand for the blood group typing market over the forecast period.
Key players in the market
Some of the key players profiled in the Blood Group Typing Market include Quotient Limited, DIAGAST, Grifols, S.A, Immucor, Inc, CareDX Inc., Agena Bioscience.Inc., Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Merck KGaA, Beckman Coulter, Inc., QIAGEN, BAG Health Care GmbH
Key Developments:
In April 2022, Grifols, a global pioneer in plasma-derived pharmaceuticals, announced its acquisition of Tiancheng (Germany) Pharmaceutical Holdings AG's 100% share capital. Grifols' completed the acquisition of Biotest AG, which is owned by Tiancheng (Germany) Pharmaceutical Holdings AG.
In March 2022, Immucor Announces New Innovations in Transplant Diagnostics This new software offering gives users of MIA FORA NGS MFlex HLA Typing assays a faster and easier NGS analysis experience. MIA FORA NGS EXPRESS will also allow users the cost-saving option of a standard Windows desktop computing system in addition to the current Linux server.
In February 2022, Grifols announced collaboration with Endpoint Health, Inc. This collaboration would help in the expansion of the product portfolio for blood group typing.
Products Covered:
• Consumables
• Instruments
• Other Products
Techniques Covered:
• Assay-Based Techniques
• Massively Parallel Sequencing Techniques
• PCR-Based & Microarray Techniques
• Other Techniques
Test Types Covered:
• Antibody Screening & Identification
• Antigen Typing
• ABO Tests
• Cross-Matching Tests
• Other Test Types
End Users Covered:
• Blood Banks
• Hospitals
• Laboratories
• Other End Users
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook